Increased levels of factor VII, fibrinogen and activity of plasminogen activator inhibitor during postprandial triglyceridemia in patients with ischemic heart disease confirmed by angiography

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 9, Issue 1, 1999, Pages 33-40

  Jastrzebska M ^a,b   Przybycien K ^a   Chelstowski, K ^a   Torbus Lisiecka, B ^a   Kornacewicz Jach, Z ^a   Naruszewicz, M ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Central Laboratory   (Poland)

Author keywords

Alimentary lipemia; Factor VII; Fibrinogen; Ischemic heart disease; Plasminogen activator inhibitor

Indexed keywords

THROMBUS;

BLOOD CLOTTING FACTOR 7; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EATING; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; METABOLISM; MIDDLE AGED; POSTPRANDIAL STATE; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; REFERENCE VALUE;

ADULT; CORONARY ANGIOGRAPHY; EATING; FACTOR VII; FIBRINOGEN; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLASMINOGEN INACTIVATORS; POSTPRANDIAL PERIOD; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REFERENCE VALUES; TRIGLYCERIDES;

EID: 0033068813     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Sirtori CR, Mancini M, Paoletti R (1990) Consensus: Hypertriglyceridaemia as a vascular risk factor. Eur Heart J 11 (Suppl. H): 44-48
2. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ (1993) Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 342: 1076-1079
3. Heinrich J, Balleisen L, Schulte H, Assman G, van de Loo J (1994) Fibrinogen and factor VII in the prediction of Coronary Risk: Results from the PROCAM Study in healthy men. Arterioscler Thromb 14: 54-59
4. Folsom AR, Kenneth KW, Davis CE, Conlan MG, Sorlie PD, Szklo M (1991) Population correlates of plasma fibrinogen and factor VII putative cardiovascular risk factors. Atherosclerosis 91: 191-205
5. Broadhurst P, Kelleher C, Hughes L, Imeson JD, Raftery EB (1990) Fibrinogen, factor VII clotting activity and coronary artery disease severity. Atherosclerosis 85: 169-173
6. Dawson S, Henney A (1992) The status of PAI-1 a risk factor for arterial and thrombotic disease: A review. Atherosclerosis 95: 105-117
7. Saha N, Heng CK, Mozoomdar BP, Reuben EM, Soh HT, Low PS, Tay JSH, Liu Y, Hong S (1995) Racial variation of factor VII activity and antigen levels and their correlates in healthy Chinese and Indians at low and high risk for coronary artery disease. Atherosclerosis 117: 33-42
8. Miller GJ, Martin JC, Mitropoulos KA, Reeves BEA, Thompson RL, Meade TW, Cooper JA, Cruickshank JK (1991) Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis 86: 163-171
9. Salomaa V, Rasi V, Pekkanen J, Jauhiainen M, Vahtera E, Pietinen P, Karhonen H, Kuulasmaa K, Ehnholm C (1993) The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity. Atherosclerosis 103: 1-11
10. Silveira A, Karpe F, Blombäck M, Steiner G, Walldius G, Hamsten A (1994) Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb 14: 60-69
11. Kapur R, Hoffman CJ, Bhushan V, Hultin MB (1996) Postprandial elevation of activated factor VII in young adults. Arterioscler Thromb Vasc Biol 16: 1327-1332
12. Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A (1996) In vivo demonstration in humans that large postprandial triglyceride-rich lipoprotein activates coagulation factor VII through the intrinsic coagulation pathway. Arterioscler Thromb Vasc Biol 16: 1333-1339
13. Miller GJ, Martin JC, Mitropoulos KA, Esnouf MP, Cooper JA, Morrissey JH, Howarth DJ, Tuddenham EGD (1996) Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency. Blood 87: 4187-4196
14. Rugman FP, Jenkins JA, Duguid JK, Maggs PB, Hay CRM (1994) Prothrombin fragment F1+2: correlations with cardiovascular risk factors. Blood Coagul Fibrinolysis 5: 335-340
15. Miller GJ, Wilkes HC, Meade TW, Bauer KA, Barzegar S, Rosenberg RD (1991) Haemostatic changes that constitute the hypercoagulable state. Lancet 338: 1079 (Letter)
16. Merlini PA, Spinola A, Oltrona L, Ardissino D, Broccolino M, Coppola R, Bottasso B, Belli C, Mannuci PM (1994) Activated factor VII and biochemical markers of activation of the haemostatic system in acute coronary syndromes. Eur Heart J 15 (Abstract Suppl.): 107
17. ten Cate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, Kass BL, Rosenberg RD (1993) The activation of factor X and prothrombin by recombinant factor Vila in vivo is mediated by tissue factor. J Clin Invest 92: 1207-1212
18. Halle M, Berg A, Baumstark MW, Keul J (1994) Hyperfibrinogenaemia is associated with a distinct high-density lipoprotein and low-density lipoprotein subclass phenotype in young healthy men. Eur Heart J 15 (Abstract Suppl.): 529
19. Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blombäck M, Wiman B (1987) Plasminogen activator inhibitor in plasma risk factor for recurrent myocardial infarction. Lancet 4: 3-9
20. Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J (1990) Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 10: 1067-1073
21. Mussoni L, Mannuci L, Sirtori M, Camera M, Maderna P, Sironi L, Tremoli E (1992) Hypertriglyceridemia and regulation of fibrinolytic activity. Arterioscler Thromb 12: 19-25
22. Andersen P, Smith P, Seljeflot I, Brataker S, Arnesen H (1990) Effects of gemfibrozil on lipids and haemostasis after myocardial infarction. Thromb Haemost 63: 174-177
23. Mehrabian M, Peter JB, Barnard RJ, Lusis AJ (1990) Dietary regulation of fibrinolytic factors. Atherosclerosis 84: 25-32
24. Mitropoulos KA, Miller GJ, Watts GF, Durrington PN (1992) Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII. Atherosclerosis 95: 119-125
25. Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Chapman J, Truffert J, Dairou F, Gennes JL, Caen JP (1989) Coagulation factor VII and plasma triglycerides: decreased catabolism as a possible mechanism of factor VII hyperactivity. Haemostasis 19: 125-130
26. Carvalho de Sousa J, Soria C, Ayrault-Jarrier M, Pastier D, Bruckert E, Amiral J, Beraziat G, Caen JP (1988) Association between coagulation factors VII and X with triglyceride-rich lipoproteins. J Clin Pathol 41: 940-944
27. Sakai T, Kisiel W (1990) Formation of tissue factor activity following incubation of recombinant human tissue factor apoprotein with plasma lipoproteins. Thromb Res 60: 213-222
28. Eichinger S, Mannucci PM, Tradati F, Arbini AA, Rosenberg RD, Bauer KA (1995) Determinants of plasma factor VII levels in humans. Blood 86: 3021-3025
29. Moor E, Hamsten A, Karpe F, Bavenholm P, Blombäck M, Silveira A (1994) Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age. Thromb Haemost 71: 707-712
30. Mabile L, Salvayre R, Bonnafe MJ, Negre-Salvayre A (1995) Oxidizability and subsequent cytotoxicity of chylomicrons to monocytic U937 and endothelial cells are dependent on dietary fatty acid composition. Free Radic Biol Med 19: 599-607
31. Mori Y, Wada H, Nagano Y, Deguchi K, Kita T, Shirakawa S (1989) Hypercoagulable state in the Watanabe heritable hyperlipidemie rabbit, an animal model for the progression of atherosclerosis. Effect of probucol on coagulation. Thromb Haemost 61: 140-143
32. Okazaki M, Zhang H, Yoshida Y, Ichino K, Nakayama S, Oguchi K (1994) Correlation between plasma fibrinogen and serum lipids in rats with hyperlipidemia induced by cholesterol free-high fructose or high cholesterol diet. J Nutr Sei Vitaminol 40: 479-489
33. Stein D, Heins M, Schoebel FC, Withold W, Friebe M, Pels K, Reinauer H, Leschke M (1995) Hyperfibrinogenemia is associated with an activation of the fibrinolytic system in patients with coronary artery disease. Abstracts submitted to the Council on Arteriosclerosis for the 68th Scientific Sessions of the American Heart Association, November 13-16, Anaheim Convention Center Anaheim, California